DÄ internationalArchive17/2007Obesity – an Introduction to Molecular Mechanisms

Review article

Obesity – an Introduction to Molecular Mechanisms

Dtsch Arztebl 2007; 104(17): A-1166

Görtzen, A; Veh, R W

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

1. Friedmann JM: Obesity in the new millenium, Nature 2000; 404: 632–4.
2. Hebebrand J, Dabrock P, Lingenfelder M, Mand E, Rief W, Viot W: Ist Adipositas eine Krankheit? Dtsch Arztebl 2004; 101(17): A 2468–74. VOLLTEXT
3. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse ob gene and its human homologue. Nature 1994; 372: 425–32. MEDLINE
4. Marx J: Cellular warriors at the battle of the bulge. Science 2003; 299: 846–49. MEDLINE
5. Schwartz MW, Woods SC, Porte Jr D, Seeley RA, Baskin DG: Central nervous system control of food intake. Nature 2000; 404: 661–70. MEDLINE
6. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656–60. MEDLINE
7. Cowley MA, Smith RG, Diano S et al.: The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003; 37: 649–61. MEDLINE
8. Blevins JE, Stanley BG, Reidelberger RD: Brain regions where cholecystokinin suppresses feeding in rats. Brain Res 2000; 860: 1–10. MEDLINE
9. Batterham RL, Cowley MA, Small CJ et al.: Gut hormone PYY3-36 physiologically inhibits food intake. Nature 2002; 418: 650–4.
10. Bays HE: Current and investigational antiobesity agents and obesity therpeutic treatment targets. Obes Res 2004; 12: 1197–211. MEDLINE
11. Small CJ, Bloom SR: Gut hormones and the control of appetite. TRENDS in Endocrinol and Metabolism 2004; 15: 259–63. MEDLINE
12. Brunetti L, Di Nisio C, Orlando G, Ferrante C, Vacca M: The regulation of feeding: a cross talk between peripheral and central signalling. Int J Immunopathol Pharmacol 2005; 18: 201–12. MEDLINE
13. Saper CB, Cou TC, Elmquist JK: The need to feed: homeostatic and hedonic control of eating. Neuron 2002; 36: 199–211. MEDLINE
14. Szczypka MS, Kwok K, Brot MD et al.: Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice. Neuron 2001; 30: 819–28. MEDLINE
15. Petrovich GD, Holland PC, Gallagher M: Amygdalar and prefrontal pathways to the lateral hypothalamus are activated by a learned cue that stimulates eating. J Neurosci 2005; 25: 8295–302. MEDLINE
16. Farooqi IS, Yeo GSH, Keogh JM et al.: Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 2000; 106: 271–9. MEDLINE
17. Cummings DE, Clement K, Purnell JQ et al.: Elevated plasma ghrelin levels in Prader-Willi syndrome. Nature Medicine 2002; 8: 643–4. MEDLINE
18. Challis BG, Yeo GS, Farooqi IS et al.: The CART gene and human obesity: mutational analysis and population genetics. Diabetes 2000; 49: 872–925. MEDLINE
19. Gibson WT, Pissios P, Trombly DJ et al.: Melanin-concentrating hormone receptor mutations and human obesity: functional analysis. Obes Res 2004; 12: 743–9. MEDLINE
20. Wang HJ, Geller F, Dempfle A et al.: Ghrelin receptor gene: identification of several sequence variants in extremely obese children and adolescents, healthy normalweight and underweight students, and children with short normal stature. J Clin Endocrinol Metab 2004; 89: 157–62. MEDLINE
21. Heid IM, Vollmert C, Hinney A et al.: Association of the 1031 MC4R allele with decreased body mass in 7 937 participants ot two population based surveys. J Med Genet 2005; 42: 21–6. MEDLINE
22. Hinney A, Friedel S, Remschmidt H, Hebebrandt J: Genetic risk factors in eating disorders. Am J Pharmacogenomics 2004; 4: 209–23. MEDLINE
23. Friedman J: Fat chance. In: Bear MF, Connors BW, Paradiso MA, eds.: Neuroscience, exploring the brain. Baltimor: Lippincott Williams & Wilkins 2001; 528–9.
24. Bays HE, Dujovne C: Anti-obesity drug development. Expert Opin Investig Drugs 2002; 11: 1189–204. MEDLINE
25. Wynne K, Park AJ, Small CJ et al.: Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects. Diabetes 2005; 54: 2390–5. MEDLINE
e1. Caro JF, Kolaczynski JW, Nyce MR et al.: Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. The Lancet 1996; 348: 159–61. MEDLINE
e2. Elmquist JK, Ahima RS, Elias CF, Flier JS, Saper CB: Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei. Proc Natl Acad Sci 1998; 95: 741–6. MEDLINE
e3. Cowley MA, Smart JL, Rubinstein M et al.: Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001; 411: 480–4. MEDLINE
e4. Considine RV, Sinha MK, Heiman ML et al.: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292–5. MEDLINE
e5. Ibrahim N, Bosch MA, Smart JL et al.: Hypothalamic proopiomelanocortin neurons are glucose responsive and express K-ATP channels. Endocrinology 2003; 144: 1331–40. MEDLINE
e6. Nakazato M, Murakami N, Date Y et al.: A role for ghrelin in the central regulation of feeding. Nature 2001; 409: 194–8. MEDLINE
e7. Inui A: Ghrelin: an orexigenic and somatotrophic signal from the stomach. Nature Reviews 2001; 2: 1–10.
e8. Sauvé D, Woodside B: Neuroanatomical specificity of prolactin-induced hyperphagia in virgin female rats. Brain Res 2000; 868: 306–14. MEDLINE
e9. Matsumoto Y, Watanabe T, Adachi Y, Itoh T, Ohtaki T, Onda H et al.: Galanin-like peptide stimulates food intake in the rat. Neurosci Let 2002; 322: 67–9. MEDLINE
e10. Jethwa PH, Small CJ, Smith KL et al.: Neuromedin U has a physiological role in the regulation of food intake and partially mediates the effects of leptin. Am J Physiol Endocrinol Metab. 2005; 289: E301–5. MEDLINE
e11. Kobelt P, Goebel M, Stengel A et al.: Bombesin but not amylin blocks the orexigenic effect of peripheral ghrelin. Am J Physiol Regul Integr Comp Physiol 2006; Epub ahead of print. MEDLINE
e12. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Grüters A: Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nature Genetics 1998; 19: 155–7. MEDLINE
e13. Baessler A, Hasinoff MJ, Fischer M et al.: Genetic linkage and association of the growth hormone secretagogue receptor (ghrelin receptor) gene in human obesity. Diabetes, 2005; 54: 259–67. MEDLINE
e14. Höybye C, Barkeling B, Espelund U, Petersson M, Thorén M: Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment. Growth Hormone & IGF Research 2003; 13: 322–7. MEDLINE
e15. Haqq AM, Farooqi IS, O`Rahilly S et al.: Serum Ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi Syndrome. J Clin Endocrinol Metab 2003; 88: 174–8. MEDLINE
e16. Bhattacharyya S, Luan J, Farooqi IS et al.: Studies of the neuromedin U-2 receptor gene in human obesity: evidence for the existence ot two ancestral forms of the receptor. J Endocrinol 2004; 183: 115–20. MEDLINE
e17. Hung CC, Pirie F, Luan J et al.: Studies of the peptide YY and neuroppeptide Y2 receptor genes in relation to human obesity and obesity-related traits. Diabetes 2004; 53: 2461–6. MEDLINE
e18. Gibson WT, Ebersole BJ, Bhattacharyya S et al.: Mutational analysis of the serotonin receptor 5HT2c in severe early-onset human obesity. Can J Physiol Pharmacol 2004; 82: 426–9. MEDLINE
e19. Sicherer verordnen. Rheinisches Ärzteblatt 2005; 9: 9.
e20. Bloom SR: Gut peptide hormones and the conrol of appetite. Vortrag auf dem 35th Annual Meeting der SfN, 2005, Washington.
e21. van Gaal LF, Rissanen AM, Scheen AJ et al.: Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 2005; 365: 1389–97. MEDLINE
e22. Bray GA, Tartaglia LA: Medicinal strategies in the treatment of obesity. Nature 2000; 404: 672–7. MEDLINE
e23. Proietto J, Fam BC, Ainslie DA, Thorburn AW: Novel anti-obesity drugs. Exp Opin Invest Drugs 2000; 9: 1317–26. MEDLINE
e24. Chaki S, Nakazato A: Recent advances in feeding suppressing agents: potential therapeutic strategy for the treatment of obesity. Expert Opin Ther Patents 2001; 11: 1677–92.